Core Viewpoint - The A-share market has seen a strong performance in the food sector, with several stocks experiencing significant gains, indicating positive market sentiment towards food companies [1]. Summary by Category Stock Performance - Sanyuan Foods (三元股份) reached the daily limit with a 9.97% increase, bringing its total market value to 9.944 billion [2]. - Anjuke Foods (安井食品) rose by 6.23%, with a market capitalization of 27.3 billion [2]. - Ketaobiotech (科拓生物) increased by 5.42%, with a total market value of 4.975 billion [2]. - Ganyuan Foods (甘源食品) saw a 4.24% rise, with a market capitalization of 5.816 billion [2]. - Tianwei Foods (天味食品) grew by 4.18%, with a total market value of 14.3 billion [2]. - ST Jiajia (ST加加) increased by 4.05%, with a market capitalization of 8.87 billion [2]. - Jiabiou (嘉必优) rose by 3.56%, with a total market value of 4.401 billion [2]. - XD Zhu Laoliu (XD朱老六) increased by 2.31%, with a market capitalization of 2.704 billion [2]. - Pinwu Foods (品屋食品) saw a 2.12% rise, with a total market value of 3.814 billion [2]. Year-to-Date Performance - Sanyuan Foods has a year-to-date increase of 50.78% [2]. - Anjuke Foods has increased by 5.31% year-to-date [2]. - Ketaobiotech has a year-to-date increase of 32.45% [2]. - Ganyuan Foods has decreased by 30.79% year-to-date [2]. - Tianwei Foods has increased by 5.96% year-to-date [2]. - ST Jiajia has a year-to-date increase of 62.79% [2]. - Jiabiou has increased by 38.53% year-to-date [2]. - XD Zhu Laoliu has a year-to-date increase of 34.56% [2]. - Pinwu Foods has increased by 19.50% year-to-date [2].

Core Viewpoint - The A-share market is experiencing a strong performance in the food sector, with several stocks showing significant gains, indicating positive market sentiment and potential investment opportunities in this industry [1] Group 1: Stock Performance - San Yuan Co., Ltd. reached the daily limit increase [1] - Anjuke Foods increased by over 6% [1] - Keta Bio surged by over 5% [1] - Ganyuan Foods and Tianwei Foods both rose by over 4% [1] - Jiabiyou saw an increase of over 3% [1]

Core Viewpoint - The stock of Jia Bi You has shown a mixed performance in recent trading sessions, with a year-to-date increase of 29% but a decline over the past 20 and 60 days, indicating volatility in investor sentiment [1][2]. Group 1: Stock Performance - On November 10, Jia Bi You's stock rose by 2.02%, reaching a price of 24.29 yuan per share, with a trading volume of 34.99 million yuan and a turnover rate of 0.87% [1]. - Year-to-date, Jia Bi You's stock has increased by 29.00%, while it has seen a decline of 7.04% over the past 20 days and 12.94% over the past 60 days [1]. - The company has appeared on the "龙虎榜" (a stock trading list) once this year, with the most recent appearance on March 14, where it recorded a net buy of 18.50 million yuan [1]. Group 2: Company Overview - Jia Bi You Biotechnology (Wuhan) Co., Ltd. was established on September 22, 2004, and went public on December 19, 2019. The company specializes in the research, production, and sales of polyunsaturated fatty acids such as ARA and DHA, as well as natural β-carotene [2]. - The main revenue sources for Jia Bi You are ARA products (76.16%), DHA products (21.24%), and other supplements (2.60%) [2]. - The company operates within the basic chemical industry, specifically in food and feed additives, and is associated with concepts such as pet economy and synthetic biology [2]. Group 3: Financial Performance - For the period from January to September 2025, Jia Bi You achieved a revenue of 428 million yuan, reflecting a year-on-year growth of 10.56%, while the net profit attributable to the parent company was 129 million yuan, marking a significant increase of 54.18% [2]. - Since its A-share listing, Jia Bi You has distributed a total of 243 million yuan in dividends, with 103 million yuan distributed over the past three years [3]. - As of September 30, 2025, the number of shareholders increased to 8,362, with an average of 20,127 circulating shares per person, a slight decrease of 1.00% from the previous period [2].

Core Viewpoint - The Ministry of Industry and Information Technology (MIIT) has announced the list of selected units for the high-performance bioreactor innovation task, aiming to enhance the supply capacity of key equipment for biological manufacturing [2][3]. Summary by Relevant Sections Task Objectives - The initiative focuses on three categories: reactor systems, key components and consumables, and industrial operating systems, with a total of nine tasks aimed at selecting and nurturing units with strong innovation capabilities and mastery of core technologies [2]. Selected Units - Notable units included in the list are: - Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences - Guangzhou Aibaitai Biotechnology - Shanghai Dongfulong - Jiangsu Weiji Wisdom - Shanghai Shunyu Hengping - Shanghai Ailite [5][6]. Task Directions - The tasks cover various directions such as: 1. Microbial parallel bioreactors 2. Cell parallel bioreactors 3. Large cell bioreactors 4. Core physicochemical parameter in-situ monitoring 5. Biological reactor intelligent industrial operating systems [5][6]. Innovation Goals - The goal is to break through several landmark technologies, cultivate typical application scenarios, and accelerate the landing and application of new technologies and products, thereby enhancing the integrated development capability of high-performance bioreactors [2].

Core Viewpoint - The stock of Jia Bi You experienced a decline of 2.00% on November 4, with a current price of 23.52 CNY per share and a total market capitalization of 3.959 billion CNY [1] Financial Performance - For the period from January to September 2025, Jia Bi You achieved a revenue of 428 million CNY, representing a year-on-year growth of 10.56%. The net profit attributable to the parent company was 129 million CNY, reflecting a significant increase of 54.18% [2] - Since its A-share listing, Jia Bi You has distributed a total of 243 million CNY in dividends, with 103 million CNY distributed over the past three years [3] Stock Market Activity - As of November 4, the stock has increased by 24.91% year-to-date, but has seen declines of 2.33% over the last five trading days, 7.69% over the last twenty days, and 15.03% over the last sixty days [1] - The stock has appeared on the "Dragon and Tiger List" once this year, with the most recent occurrence on March 14, where it recorded a net purchase of 18.5019 million CNY [1] Shareholder Information - As of September 30, 2025, the number of shareholders for Jia Bi You was 8,362, an increase of 1.01% from the previous period. The average number of circulating shares per person decreased by 1.00% to 20,127 shares [2]

Core Viewpoint - The company, Jia Bi You, announced a share buyback program, indicating a strategic move to enhance shareholder value and confidence in the company's future prospects [2] Summary by Categories Share Buyback Details - As of October 31, 2025, the company has repurchased a total of 1,060,573 shares through the Shanghai Stock Exchange, representing 0.63% of the company's total share capital [2]

Core Viewpoint - Jia Bi You (688089.SH) has announced a share buyback program, indicating a strategic move to enhance shareholder value through repurchase of shares [1] Summary by Category Share Buyback Details - The company has repurchased a total of 1.0606 million shares, which represents 0.63% of its total share capital [1] - The highest transaction price during the buyback was 28.58 CNY per share, while the lowest was 23.52 CNY per share [1] - The total amount spent on the buyback reached 27.9213 million CNY, excluding transaction fees such as stamp duty and commissions [1]

Group 1 - The company, Jiabiyou, announced a share buyback of approximately 1.06 million shares, representing 0.63% of its total share capital of about 168 million shares, with a total transaction amount of approximately 27.92 million yuan [1] - The highest transaction price during the buyback was 28.58 yuan per share, while the lowest was 23.52 yuan per share [1] - As of the report, Jiabiyou's market capitalization stands at 4 billion yuan [1] Group 2 - For the fiscal year 2024, Jiabiyou's revenue composition is as follows: human nutrition accounts for 94.27%, animal nutrition for 2.96%, other businesses for 2.4%, and personal care and cosmetics for 0.38% [1]

| 回购方案首次披露日 | 2025 年 月 | 1 | 25 | 日 | | --- | --- | --- | --- | --- | | 回购方案实施期限 | 董事会审议通过后 12 个月内 | | | | | 预计回购金额 | 1,500 万元（含）-3,000 | | | 万元（含） | | 回购用途 | □减少注册资本 用于员工持股计划或股权激励 | | | | | | □用于转换公司可转债 | | | | | | □为维护公司价值及股东权益 | | | | | 累计已回购股数 | 股 1,060,573 | | | | | 累计已回购股数占总股本比例 | 0.63% | | | | | 累计已回购金额 | 27,921,296.05 元 | | | | | 实际回购价格区间 | 23.52 元/股~28.58 元/股 | | | | 证券代码：688089 证券简称：嘉必优 公告编号：2025-080 嘉必优生物技术（武汉）股份有限公司 关于第二期以集中竞价交易方式回购公司股份的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确 ...

证券代码：688089 证券简称：嘉必优 公告编号：2025-079 嘉必优生物技术（武汉）股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要风险提示： 案件所处的诉讼阶段：二审终审判决 涉案金额：原告诉请判决被上诉人支付经济损失人民币 500 万元，维权 合理费用人民币 15 万元及本案相关诉讼费用。 一、诉讼基本情况 对上市公司影响：本次诉讼判决为终审判决，公司在本次案件中无需承 担责任，也无需承担案件受理费，对公司财务状况及经营成果不会产生重大影响。 本案全部诉讼费用。具体内容详见 2021 年 12 月 1 日在上海证券交易所网站 （www.sse.com.cn）披露的《嘉必优生物技术（武汉）股份有限公司关于涉及诉 讼的公告》（公告编号：2021-044）。 2021 年 12 月，中科鸿基生物科技有限公司（以下简称"中科鸿基"）因商业 秘密纠纷对嘉必优生物技术（武汉）股份有限公司（以下简称"本公司"）、全资 子公司武汉中科光谷绿色生物技术有限公司（以下简称"中科光谷"）及汤臣倍健 股份有限公司（以 ...